E. Powell

K. Irvine, A. Russell, K. Stuart, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair.

M. Sweet, E. Powell, Glen M Scholz, 2017, Seminars in cell & developmental biology.

Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor‐α and cytochrome P450 2E1

D. Purdie, A. Clouston, N. Pandeya, 2003, Journal of gastroenterology and hepatology.

Successful in vitro fertilization and pregnancy in a patient with autoimmune chronic active hepatitis and cirrhosis

E. Powell, D. Molloy, 1995, Journal of gastroenterology and hepatology.

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial

Jennifer H. Martin, K. Irvine, P. Valery, 2017, Trials.

Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)

A. Barnett, I. Hickman, P. Valery, 2020, BMC Health Services Research.

Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis

K. Irvine, K. Stuart, P. Valery, 2020, Internal medicine journal.

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis

Jennifer H. Martin, K. Irvine, K. Stuart, 2017, World journal of gastroenterology.

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

D. Purdie, J. Prins, I. Hickman, 2003, Journal of hepatology.

Nonalcoholic fatty liver disease: is all the fat bad?

A. Clouston, E. Powell, E. Powell, 2004, Internal medicine journal.

The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

R. Hanson, E. Powell, J. Searle, 1990, Hepatology.

New Paradigms in the Histopathology of NAFLD

K. Irvine, A. Clouston, E. Powell, 2014, Current Hepatology Reports.

Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others.

A. Clouston, E. Powell, J. R. Jonsson, 2007, Clinics in liver disease.

Steatosis is a cofactor in liver injury in hemochromatosis.

D. Purdie, L. Powell, A. Clouston, 2005, Gastroenterology.

Chronic hepatitis C and steatosis

A. Clouston, E. Powell, J. R. Jonsson, 2004 .

Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: An aid to diagnosis

L. Powell, E. Powell, L. Fletcher, 1991, Hepatology.

Steatohepatitis associated with limb lipodystrophy.

R. Mortimer, E. Powell, J. Searle, 1989, Gastroenterology.

Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease

M. Volk, S. McPhail, Neta Moses, 2015, BMJ Open.

[113] PROGRESSIVE FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS - ASSOCIATION WITH ALTERED REGENERATION AND A DUCTULAR REACTION

H. Tilg, B. Neuschwander‐Tetri, A. Moschen, 2007 .

Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium

K. Stuart, E. Powell, H. Liu, 2020, Journal of gastroenterology and hepatology.

Haemochromatosis: a clinical update for the practising physician

L. Powell, E. Powell, D. Radford-Smith, 2018, Internal medicine journal.

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease

V. Wong, D. Booth, T. Berg, 2015, Nature Communications.

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests

K. Irvine, A. Russell, K. Stuart, 2021, Hepatology communications.

Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers

I. Scott, P. O’Rourke, K. Irvine, 2014, BMC Gastroenterology.

Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early intervention

K. Irvine, Sailesh Kumar, G. Feeney, 2013, Internal medicine journal.

Multimorbidity and polypharmacy in diabetic patients with NAFLD

K. Irvine, A. Russell, K. Stuart, 2017, Medicine.

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

J. Kaldor, G. Dore, M. Law, 2003, International journal of epidemiology.

Heterogeneity of fibrosis patterns in non‐alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

Rachel M. Brown, H. Tilg, B. Neuschwander‐Tetri, 2010, Liver international : official journal of the International Association for the Study of the Liver.

GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.

M. Waters, J. Barclay, E. Powell, 2011, Endocrinology.

Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism

E. Powell, P. Kroon, 1992, Journal of gastroenterology and hepatology.

Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis

K. Irvine, A. Russell, K. Stuart, 2018, Internal medicine journal.

Measurement of mRNA by quantitative PCR with a nonradioactive label.

E. Powell, P. Kroon, Elizabeth E. Powell, 1992, Journal of lipid research.

Detection of male DNA in the liver of female patients with primary biliary cirrhosis.

D. Crawford, L. Powell, A. Clouston, 2000, Journal of hepatology.

Longitudinal Change in Simple Scores Identifies Fibrosis Status in People With Nonalcoholic Fatty Liver Disease.

K. Irvine, P. Valery, A. Clouston, 2020, Journal of clinical gastroenterology.

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes.

K. Schroder, M. Sweet, D. Fairlie, 2018, JCI insight.

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity

P. O’Rourke, K. Irvine, J. Tate, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Portal, but not lobular, macrophages express matrix metalloproteinase‐9: association with the ductular reaction and fibrosis in chronic hepatitis C

M. Sweet, Sandrine Roy, P. O’Rourke, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics

S. McPhail, P. Valery, E. Powell, 2020, Hepatology communications.

Awareness and opinions of non‐alcoholic fatty liver disease by hospital specialists

A. Clouston, E. Powell, L. Horsfall, 2013, Internal medicine journal.

Liver, lipoproteins and disease: II. Clinical relevance of disordered cholesterol metabolism in liver disease

E. Powell, P. Kroon, 1992, Journal of gastroenterology and hepatology.

IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study

S. Mallal, G. Stewart, D. Booth, 2011, PLoS medicine.

IL 28 B , HLA-C , and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort : A Cross-Sectional Study

S. Mallal, G. Stewart, D. Booth, 2011 .

Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

D. Purdie, E. Powell, J. R. Jonsson, 1999, Hepatology.

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

D. Booth, T. Berg, G. Ahlenstiel, 2013, Genes and Immunity.

C282Y and H63D Mutations in the HFE Gene Are Not Associated With Porphyria Cutanea Tarda in Bulgaria

D. Purdie, A. Clouston, E. Powell, 1999 .

Virus‐specific CD8+ T lymphocytes within the normal human liver

P. Klenerman, M. Lucas, S. Sierro, 2004, European journal of immunology.

Improvement in chronic hepatocerebral degeneration following liver transplantation.

J. Chalk, P. Parkin, M. Pender, 1990, Gastroenterology.

Non‐alcoholic fatty liver disease: raising awareness of a looming public health problem

E. Powell, Lucy Gracen, 2021, The Medical journal of Australia.

Inhibitors of class I histone deacetylases attenuate thioacetamide‐induced liver fibrosis in mice by suppressing hepatic type 2 inflammation

K. Schroder, M. Sweet, D. Fairlie, 2019, British journal of pharmacology.

Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury

M. Sweet, R. Lang, A. Blumenthal, 2015, Fibrogenesis & tissue repair.

Towards collaborative management of non‐alcoholic fatty liver disease: a ‘real‐world’ pathway for fibrosis risk assessment in primary care

S. McPhail, W. Rosenberg, K. Irvine, 2021, Internal medicine journal.

The Patient’s Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age

T. Rahman, Paul John Clark, K. Stuart, 2021, Hepatology communications.

Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver disease

S. McPhail, K. Irvine, E. Powell, 2016, Internal medicine journal.

Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation

S. Jose, K. Irvine, E. Powell, 2016, PloS one.

Not every cell is as it seems: a role for ductular epithelial cells in fibrosis?

A. Clouston, E. Powell, J. R. Jonsson, 2010, Gut.

Hepatic progenitor cell–mediated regeneration and fibrosis: Chicken or egg?

A. Clouston, E. Powell, J. R. Jonsson, 2009, Hepatology.

Lymphocyte apoptosis and cell replacement in human liver allografts

A. Kelso, A. Clouston, E. Powell, 2002, Transplantation.

Causes and Consequences of Innate Immune Dysfunction in Cirrhosis

D. Hume, K. Irvine, E. Powell, 2019, Front. Immunol..

Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes.

A. Clouston, E. Powell, R. Strong, 2000, Journal of hepatology.

Expression of cytokines and factors modulating sinusoidal leucocytes apoptosis by human

A. Clouston, E. Powell, Y. Morotomi, 2000 .

Unusual Iron and Copper Studies in a Patient with Liver Injury and Normocytic Anemia.

J. Ungerer, E. Powell, R. Ruddell, 2020, Clinical chemistry.

Engaging primary care clinicians in the assessment of NAFLD

P. Valery, E. Powell, 2019, Nature Reviews Gastroenterology & Hepatology.

Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection.

E. Powell, A. Bansal, P. Hogan, 1997, Clinical immunology and immunopathology.

Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration.

M. Sweet, B. Gabrielli, G. Thomas, 2014, World journal of gastroenterology.

BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin.

P. O’Rourke, K. Irvine, J. Ungerer, 2013, Alcoholism, clinical and experimental research.

Magnetic resonance imaging and spectroscopy for monitoring liver steatosis

Azmat Ali, Susan Ash, G. Cowin, 2008, Journal of magnetic resonance imaging : JMRI.

Metabolic Factors and Non-Alcoholic Fatty Liver Disease as Co-Factors in Other Liver Diseases

A. Clouston, E. Powell, J. Jonsson, 2010, Digestive Diseases.

C ASE R EPORT: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy

D. Crawford, A. Clouston, C. Maguire, 1999, Journal of gastroenterology and hepatology.

CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.

D. Duffy, G. Radford-Smith, D. Purdie, 2004, Genes and immunity.

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study

Jennifer H. Martin, K. Irvine, P. Valery, 2016, BMC Gastroenterology.

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

Thomas Berg, Antonina Smedile, Melanie Bahlo, 2009, Nature Genetics.

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

D. Purdie, J. Prins, I. Hickman, 2002, Gut.

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

M. Richardson, D. Purdie, A. Clouston, 2005, Gut.

NON-RESPONSE TO ANTIVIRAL THERAPY IS ASSOCIATED WITH OBESITY AND INCREASED HEPATIC EXPRESSION OF SOCS-3 IN PATIENTS WITH CHRONIC HEPATITIS C , VIRAL GENOTYPE 1 .

M. Richardson, D. Purdie, A. Clouston, 2005 .

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation.

D. Purdie, A. Clouston, N. Pandeya, 2001, Journal of hepatology.

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

A. Clouston, E. Powell, G. Macdonald, 1999, Hepatology.

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

T. Asselah, P. Marcellin, V. Pazienza, 2006, Gastroenterology.

Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis

Shelly C. Lu, R. Schwabe, M. Sweet, 2019, Science Translational Medicine.

Non-alcoholic fatty liver disease

V. Wong, E. Powell, M. Rinella, 2021, The Lancet.

The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

K. Irvine, C. Winterford, A. Clouston, 2014, Hepatology.

Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers

J. Connolly, Bernett Lee, K. Irvine, 2016, PloS one.

CCR5-Δ32 mutation is strongly associated with primary sclerosing cholangitis

D. Duffy, G. Radford-Smith, D. Purdie, 2004, Genes and Immunity.

Interleukin‐32: A new proinflammatory cytokine involved in hepatitis C virus‐related liver inflammation and fibrosis

H. Tilg, A. Moschen, R. Bartenschlager, 2011, Hepatology.

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

D. Purdie, C. Hawley, C. Hong, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection

M. McGuckin, A. Clouston, E. Powell, 2011, Journal of gastroenterology and hepatology.

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.

P. O’Rourke, A. Clouston, E. Powell, 2008, Journal of hepatology.

IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis

D. Booth, T. Berg, A. Mangia, 2017, Nature Genetics.

Recognition of Genetic Factors Influencing the Progression of Hepatitis C

D. Purdie, A. Clouston, E. Powell, 2008, Molecular Diagnosis & Therapy.

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.

Y Ando, D. Purdie, Y. Ando, 2001, Gastroenterology.

Host genetic factors influence disease progression in chronic hepatitis C

D. Purdie, A. Clouston, E. Powell, 2000, Hepatology.

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

H. Tilg, B. Neuschwander‐Tetri, A. Moschen, 2007, Gastroenterology.

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C

P. O’Rourke, A. Clouston, E. Powell, 2008, Hepatology.

Liver repercussions of defective gut surveillance

K. Schroder, K. Irvine, E. Powell, 2012, Hepatology.

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

T. Berg, A. Mangia, J. Nattermann, 2019, Scientific Reports.

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

Katherine R. Smith, G. Stewart, D. Booth, 2011, Genome Medicine.

Khat‐associated hepatitis

Jennifer H. Martin, E. Powell, G. Lampe, 2013, The Medical journal of Australia.

Interaction of non-alcoholic fatty liver disease with other liver diseases.

A. Clouston, E. Powell, 2002, Best practice & research. Clinical gastroenterology.

Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection

W. Gu, G. Bishop, G. McCaughan, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

University of Dundee Association of Liver Injury From Specific Drugs , or Groups of Drugs , With Polymorphisms in HLA and Other Genes in a Genome-wide Association Study

M. Daly, M. Nelson, Yufeng Shen, 2022 .

Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient.

D. Nicol, C. Hawley, D. Johnson, 2000, Transplantation.

Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.

B. Neuschwander‐Tetri, D. Kleiner, M. Yeh, 2022, Journal of hepatology.

Weight‐based tacrolimus trough concentrations post liver transplant

Jennifer H. Martin, E. Powell, G. Macdonald, 2019, Internal medicine journal.

Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury

M. Richardson, D. Purdie, A. Clouston, 2004, Hepatology.

Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease

M. Sweet, M. Weger, M. Masoodi, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Association Between Apolipoprotein E ɛ4 and Neuropsychiatric Symptoms During Interferon α Treatment for Chronic Hepatitis C

D. Purdie, N. Pandeya, E. Powell, 2004 .

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

T. Berg, A. Mangia, J. Nattermann, 2016, Nature Communications.

MBOAT 7 rs 641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

T. Berg, A. Mangia, J. Nattermann, 2016 .

Macrophage secretory products induce an inflammatory phenotype in hepatocytes.

M. Sweet, G. Thomas, Alun Jones, 2012, World journal of gastroenterology.

Interferon- l rs12979860 genotype and liver ﬁbrosis in viral and non-viral chronic liver disease

D. Booth, T. Berg, A. Mangia, 2015 .

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease

K. Irvine, A. Russell, E. Powell, 2021, Scientific Reports.

Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis.

Meghna Talekar, K. Irvine, Ranjeny Thomas, 2018, Metabolism: clinical and experimental.

Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia

M. Larkin, M. Toombs, Paul John Clark, 2021, EClinicalMedicine.

Assessment of health‐related quality of life and health utilities in Australian patients with cirrhosis

S. McPhail, T. Rahman, Paul John Clark, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)

S. McPhail, T. Rahman, Paul John Clark, 2020, Patient preference and adherence.

Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians

M. Toombs, K. Irvine, Paul John Clark, 2020, International Journal for Equity in Health.

Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians

S. McPhail, T. Rahman, Paul John Clark, 2019, EClinicalMedicine.

Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

M. Volk, S. McPhail, T. Rahman, 2017, Internal medicine journal.

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease

K. Irvine, A. Russell, J. Connor, 2017, Canadian journal of gastroenterology & hepatology.

A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C

M. Richardson, D. Purdie, A. Clouston, 2005, Journal of Medical Genetics.

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

G. Cowin, G. Galloway, M. Benson, 2009, Journal of hepatology.

Identifying areas of need relative to liver disease: geographic clustering within a health service district.

S. McPhail, K. Irvine, M. Janda, 2016, Australian health review : a publication of the Australian Hospital Association.

CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites.

S. Jose, M. Sweet, S. Lukowski, 2016, JCI insight.

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

D. Booth, T. Berg, A. Mangia, 2016, Hepatology.

Steatosis: Co‐factor in other liver diseases

A. Clouston, E. Powell, J. Jonsson, 2005, Hepatology.

Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis

M. Richardson, A. Demetris, A. Clouston, 2005, Hepatology.

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

K. Irvine, J. Ungerer, A. Clouston, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Spatiotemporal Characterization of the Cellular and Molecular Contributors to Liver Fibrosis in a Murine Hepatotoxic-Injury Model.

G. Boyle, L. Beattie, G. Hill, 2016, The American journal of pathology.

Nonalcoholic fatty liver disease burden: Australia, 2019–2030

H. Razavi, J. George, S. Strasser, 2020, Journal of gastroenterology and hepatology.

Adiponectin and its receptors in patients with chronic hepatitis C.

H. Tilg, A. Moschen, M. Richardson, 2005, Journal of hepatology.

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies

P. Valery, V. Bansal, E. Powell, 2020, BMJ open gastroenterology.

Jennifer H. Martin, K. Irvine, K. Stuart, 2019, Hepatology communications.

Optimising care of patients with chronic disease: patient‐oriented education may improve disease knowledge and self‐management

Jennifer H. Martin, K. Irvine, P. Valery, 2017, Internal medicine journal.

Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C.

I. Scott, M. Khatun, E. Powell, 2013, Australian Health Review.

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

V. de Lédinghen, C. Canivet, T. Decaens, 2022, Hepatology.

G. Holtmann, B. Kendall, Paul John Clark, 2016, Alimentary pharmacology & therapeutics.

FibroGENE: A gene-based model for staging liver fibrosis.

Thomas Berg, Manuel Romero-Gómez, Duncan McLeod, 2016, Journal of hepatology.

Weight reduction in patients with chronic hepatitis improves liver histology and biochemistry

J. Prins, A. Clouston, E. Powell, 2000 .

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism

D. Anthony, K. Irvine, E. Powell, 2022, PLoS ONE.

Obesity management in liver clinics: Translation of research into clinical practice

I. Hickman, M. Banks, E. Powell, 2007, Journal of gastroenterology and hepatology.

Nonalcoholic fatty liver disease burden: Australia, 2019–2030

H. Razavi, J. George, S. Strasser, 2020, Journal of Gastroenterology and Hepatology.

Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis

S. McPhail, T. Rahman, Paul John Clark, 2020, Internal medicine journal.

Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM

P. Valery, E. Powell, L. Horsfall, 2021, BMJ open gastroenterology.

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

D. Purdie, J. Prins, I. Hickman, 2004, Gut.

Remoteness of residence predicts tumor stage, receipt of treatment, and mortality in patients with hepatocellular carcinoma

Paul John Clark, P. Valery, E. Powell, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Ascites Bacterial Burden and Immune Cell Profile Are Associated with Poor Clinical Outcomes in the Absence of Overt Infection

K. Irvine, G. Rogers, M. Morrison, 2015, PloS one.

Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis

K. Irvine, A. Russell, P. Valery, 2020, Hepatology communications.

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety

K. Irvine, K. Stuart, P. Valery, 2021, Pharmaceuticals.

Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation.

D. Gill, A. Clouston, E. Powell, 1999, Transplantation.

Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

D. Hume, K. Irvine, E. Powell, 2022, Digestive Diseases.

IL:32: A new pro-inflammatory cytokine involved in HCV-related liver inflammation and fibrosis

H. Tilg, A. Moschen, R. Bartenschlager, 2009 .

Kupffer cells and hepatocyte metabolism: A two‐way street?

M. Waters, E. Powell, J. Jonsson, 2009, Hepatology.

Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: An aid to diagnosis

E. Powell, L. Fletcher, J. Halliday, 1991, Hepatology.

GH (Growth Hormone)-Dependent STAT5 Signaling Plays an Important Role in Hepatic Lipid Metabolism

M. Waters, J. Barclay, E. Powell, 2010 .

Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study

S. Bell, C. Wainwright, P. Schluter, 2004, Thorax.